NIH-funded research Fellowship grant

Activating a protein to understand pancreatic beta cell dysfunction in diabetes

Official title: Forced Activation of ATF6 Drives Pancreatic Beta Cell Dysfunction

Funded at Weill Medical Coll of Cornell Univ · NIH-11082195 · Data updated 2026-11-12

This study is looking at how turning on a certain protein in the pancreas might help improve the way insulin-producing cells work, which could be really helpful for people with Type 2 Diabetes.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionWeill Medical Coll of Cornell Univ
NIH-funded
Lab location1 site (New York, United States)
Project startMarch 18, 2024
Project endMarch 17, 2027
Funding year2025
Award (this year)$48,974
NIH project number5F31DK136225-02
Project IDNIH-11082195 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Type 2 Diabetes or those at risk of developing the condition.

Less likely to help

Patients with Type 1 Diabetes or those without any form of diabetes may not receive direct benefits from this research.

What this research studies

This research investigates how activating a specific protein, ATF6α, affects the function of pancreatic beta cells, which are crucial for insulin production and blood sugar regulation. The study uses genetically modified mice to observe the effects of this activation on glucose tolerance and insulin secretion. By exposing these mice to a pharmacological agent, researchers can control the timing and location of ATF6α activation, allowing for a detailed analysis of its role in diabetes. The findings aim to uncover mechanisms that contribute to beta cell dysfunction in Type 2 Diabetes.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for improving insulin production and glucose regulation in patients with Type 2 Diabetes.

How similar studies have gone: Previous research has shown that targeting the Unfolded Protein Response can have beneficial effects in other models of diabetes, suggesting potential for success in this approach.

Where this research is happening

  • Weill Medical Coll of Cornell Univ
    New York, United States
    Active

Researchers

  • Principal investigator: Rappa, Andrew — Weill Medical Coll of Cornell Univ
  • Study coordinator: Rappa, Andrew

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.